20 Geographic Atrophy Clinical Trials in Rochester, MN (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Geographic Atrophy Studies in Rochester

NCT02523118Recruiting

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/o...

Rochester, MN1,350 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT06080698Recruiting

Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy f...

Rochester, MNNA1,030 participantsJohns Hopkins University

View Study Details

NCT04557462Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who have completed either the CLNP023X2203 or CLNP023A23...

Rochester, MNPHASE3540 participantsNovartis Pharmaceuticals

View Study Details

NCT06005493Recruiting

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

This research is designed to determine if experimental treatment with AZD5863, a T cell-engaging bispecific antibody that targets Claudin 18.2 (CLDN18.2) and CD3, is safe, tolerable and has anti-cance...

Rochester, MNPHASE1392 participantsAstraZeneca

View Study Details

NCT06349642Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

This study is being done to collect tissue samples to test how accurately a tumor response platform, Elephas, can predict clinical response across multiple types of immunotherapies, chemoimmunotherapy...

Rochester, MN324 participantsMayo Clinic

View Study Details

NCT04411823Recruiting

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy....

Rochester, MNNA200 participantsMayo Clinic

View Study Details

NCT06630234Recruiting

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST. The study will use a modular approach with each module...

Rochester, MNPHASE1120 participantsDeciphera Pharmaceuticals, LLC

View Study Details

NCT02945579Recruiting

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

This clinical trial studies eliminating surgery and/or radiation therapy in treating breast cancer patients. In HER2 positive and triple negative breast cancers, after systemic therapy, when image-gui...

Rochester, MNNA120 participantsM.D. Anderson Cancer Center

View Study Details

NCT07015424Recruiting

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a...

Rochester, MNNA108 participantsBoston Scientific Corporation

View Study Details

NCT07282587Recruiting

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG)....

Rochester, MNPHASE290 participantsJazz Pharmaceuticals

View Study Details

NCT07161544Recruiting

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

The purpose of the 039-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-039 in participants with Stargardt disease secondary to a biallelic mutation of the...

Rochester, MNPHASE175 participantsAAVantgarde Bio Srl

View Study Details

NCT07419841Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

This is a Phase 1, open-label, first-in-human study of CTX-10726 monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 Cohorts: Cohort 1 Dose Escal...

Rochester, MNPHASE170 participantsCompass Therapeutics

View Study Details

NCT07406633Recruiting

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

This study will test an experimental drug called KQB198 in combination with imatinib. The goal is to determine if this combination is safe and tolerable and assess how effective the combination is at ...

Rochester, MNPHASE246 participantsKumquat Biosciences Inc.

View Study Details

NCT05753306Recruiting

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

This phase II clinical trial tests how well robotic cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating patients with gastric cancer that has spread to the tissue that line...

Rochester, MNPHASE240 participantsMayo Clinic

View Study Details

NCT06175403Recruiting

A Study of Niacin Regulation

Adults who gain most of their excess weight in the abdominal area typically do not respond to things that "turn off" fat cells the same way as lean people. The researchers are trying to understand why...

Rochester, MNEARLY_PHASE132 participantsMayo Clinic

View Study Details

NCT06306963Recruiting

Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias

The researchers are trying to find out more about Gastric Antral Vascular Ectasia (GAVE). This is a condition that affects the blood vessels in the stomach, leading to their enlargement and possible b...

Rochester, MN30 participantsMayo Clinic

View Study Details

NCT06083766Recruiting

Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People

The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology....

Rochester, MN24 participantsMayo Clinic

View Study Details

NCT05205343Recruiting

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG....

Rochester, MN20 participantsM.D. Anderson Cancer Center

View Study Details

NCT03959878Recruiting

Feasibility of a Constant Pressure Skin Disk (CPSD) in Enteral Tubes.

Researchers are gathering information on one specific part of a feeding tube, known as the adjustable skin disk. Researchers are trying to see if a new type of adjustable skin disk, called a Constant ...

Rochester, MNNA20 participantsMayo Clinic

View Study Details

NCT06676579Recruiting

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

The purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic Imunoglobulin A Nephropathy (IgAN) and h...

Rochester, MNPHASE216 participantsMayo Clinic

View Study Details

About Geographic Atrophy Clinical Trials in Rochester

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 20 geographic atrophy clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 4,647 participants. Research is being sponsored by Children's Hospital Medical Center, Cincinnati, Johns Hopkins University, Novartis Pharmaceuticals and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Rochester — FAQ

Are there geographic atrophy clinical trials in Rochester?

Yes, there are 20 geographic atrophy clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 20 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 12, 2026 from ClinicalTrials.gov